Search results
Could third-party candidate RFK Jr. make a splash in battleground state North Carolina?
Gannett via AOL· 3 hours ago“However, the Trump lead over Biden has been reduced to 2 percent – inside the confidence interval of the poll. Joe Biden has improved his poll numbers ...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 1 day agoIn ACE-Breast-02, ARX788 managed to prolong progression-free survival (PFS) compared to LC, with...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoThese safety results are in keeping with the known toxicities of Enhertu and Perjeta....
Placing COVID patients in skilled nursing facilities led to increased cases, deaths, study finds
Center for Infectious Disease Research and Policy· 16 hours agoOutcomes were assessed during a 15-week follow-up period. The authors found that exposed SNFs had a...
Council Post: What Leaders Can Learn From Modern Anti-Money Laundering Techniques
Forbes· 2 days agoAshley Stephenson is the CTO of Corero Network Security, a leading provider of DDoS protection...
ASCO 24: Data shows survival benefit with J&J’s subcutaneous Rybrevant
Clinical Trials Arena via Yahoo Finance· 4 days agoAdditionally, the median PFS benefit of the SC formulation, was 6.1 months vs 4.3 months (hazard...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Valley City Times Record· 2 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...
Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib...
Valley City Times Record· 2 days agoJohnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as a first-line treatment in patients with advanced ...
Determinants of incomplete penta vaccination among children aged 12 to 23 months in South-West...
Nature· 5 days agoA Community based case–control study was conducted at Illu Aba Bor, mettu district, south west Ethiopia from April 24-May 23, 2022. Mettu is located in Oromia Regional State at a distance of ...
May 31 2024 This Week in Cardiology
Medscape· 5 days agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple...